TY  - GEN
AU  - Nesbitt,Andrew
AU  - Fossati,Gianluca
AU  - Bergin,Marianne
AU  - Stephens,Paul
AU  - Stephens,Sue
AU  - Foulkes,Roly
AU  - Brown,Derek
AU  - Robinson,Martyn
AU  - Bourne,Tim
TI  - Mechanism of action of certolizumab pegol (CDP870): in vitro comparison with other anti-tumor necrosis factor alpha agents
SN  - 1078-0998
PY  - 2008///0206
KW  - Adalimumab
KW  - Anti-Inflammatory Agents
KW  - pharmacology
KW  - Antibodies, Monoclonal
KW  - Antibodies, Monoclonal, Humanized
KW  - Apoptosis
KW  - drug effects
KW  - Blood Cells
KW  - Cells, Cultured
KW  - Certolizumab Pegol
KW  - Drug Evaluation
KW  - Etanercept
KW  - Granulocytes
KW  - Humans
KW  - Immunoglobulin Fab Fragments
KW  - Immunoglobulin G
KW  - Inflammatory Bowel Diseases
KW  - drug therapy
KW  - Infliximab
KW  - Interleukin-1beta
KW  - biosynthesis
KW  - Lipopolysaccharides
KW  - Lymphocytes
KW  - cytology
KW  - Monocytes
KW  - Polyethylene Glycols
KW  - Receptors, Tumor Necrosis Factor
KW  - Tumor Necrosis Factor-alpha
KW  - antagonists & inhibitors
N1  - Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1002/ibd.20225
ER  -